Tsopanoglou N E, Zioudrou C, Tsilibary E C, Charonis A S
Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis 55455, USA.
Microcirculation. 1995 Sep;2(3):283-7. doi: 10.3109/10739689509146774.
To determine whether putrescine, a naturally occurring polyamine, is able to prevent nonenzymatic glycosylation-induced cross-linking of basement membrane components. Cross-linking, leading to the formation of advanced glycosylation end products (AGEs) has been proposed as a major mechanism contributing to structural and functional changes of the vascular wall, thus leading to microangiopathy.
Laminin, a major basement membrane glycoprotein present in the microvasculature, was isolated and incubated in the presence of high glucose concentrations, in order to generate an in vitro diabetic environment. Putrescine was either present or absent from the incubation mixture. Formation of cross-links was assessed by two independent methods: gel electrophoresis and development of characteristic fluorescence.
Putrescine inhibited in a dose-dependent manner the formation of slower mobility bands in gel electrophoresis. Quantitation of the development of fluorescence characteristic of glycosylation-induced cross-links demonstrated that putrescine inhibited the formation of fluorescent products.
Putrescine may be a promising compound for inhibition of protein cross-linking and, therefore, could be used in the prevention of diabetic microangiopathy.
确定腐胺(一种天然存在的多胺)是否能够预防非酶糖基化诱导的基底膜成分交联。交联会导致晚期糖基化终产物(AGEs)的形成,这一过程被认为是导致血管壁结构和功能改变进而引发微血管病变的主要机制。
层粘连蛋白是微血管中主要的基底膜糖蛋白,将其分离出来并在高糖浓度环境下孵育,以营造体外糖尿病环境。孵育混合物中添加或不添加腐胺。通过两种独立方法评估交联的形成:凝胶电泳和特征性荧光的产生。
腐胺以剂量依赖方式抑制凝胶电泳中迁移较慢条带的形成。对糖基化诱导交联的荧光特征发展进行定量分析表明,腐胺抑制了荧光产物的形成。
腐胺可能是一种有前景的抑制蛋白质交联的化合物,因此可用于预防糖尿病微血管病变。